West Tower Group’s Clorox CLX Stock Holding History

West Tower Group’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-105	Closed	-$13.8K	–	556
2023 Q3	$13.8K	Sell	105 -21	-17%	-$3.19K	0.01%	359
2023 Q2	$20K	Buy	+126	New	+$20.3K	0.01%	340

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

West Tower Group's CLX Position: Q4 2023 in Review

West Tower Group sold out of Clorox (CLX) in Q4 2023, closing a stake of 105 shares — an estimated $13.8K sold.

West Tower Group first reported a position in CLX in Q2 2023 and held it in 2 quarters. The position peaked at $20K in Q2 2023. 1,107 funds tracked by Wall St. Rank hold CLX as of Q4 2023.

West Tower Group reported no remaining Clorox position as of Q4 2023 after selling out during the quarter.
West Tower Group sold 105 Clorox shares in Q4 2023, an estimated $13.8K.
West Tower Group first reported a position in Clorox in Q2 2023 and held it in 2 quarters.
West Tower Group's Clorox position peaked at $20K in Q2 2023.
1,107 funds tracked by Wall St. Rank held Clorox as of Q4 2023.

Based on West Tower Group's 13F filing for Q4 2023, filed 14 Feb 2024.